Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment

被引:8
作者
Cochet, A. [1 ,2 ,3 ]
Kanoun, S. [1 ,2 ]
Humbert, O. [1 ,2 ,3 ]
Walker, P. -M. [2 ,3 ]
Cormier, L. [4 ]
Crehange, G. [2 ,5 ]
Brunotte, F. [1 ,2 ,3 ]
机构
[1] Ctr Georges Francois Leclerc, Nucl Med Serv, F-21079 Dijon, France
[2] Univ Bourgogne, UMR 6306, Lab Elect Informat & Image Le2i, F-21078 Dijon, France
[3] CHU Dijon, Serv Spect RMN, F-21079 Dijon, France
[4] CHU Dijon, Serv Urol, F-21079 Dijon, France
[5] Ctr Georges Francois Leclerc, Serv Radiotherapie, F-21079 Dijon, France
来源
CANCER RADIOTHERAPIE | 2014年 / 18卷 / 5-6期
关键词
Multimodality MRI; PET; Prostate cancer; Biochemical failure; POSITRON-EMISSION-TOMOGRAPHY; MULTIPARAMETRIC MAGNETIC-RESONANCE; RADICAL RETROPUBIC PROSTATECTOMY; EXTERNAL-BEAM RADIOTHERAPY; LYMPH-NODE METASTASES; CONTRAST-ENHANCED MRI; C-11-CHOLINE PET/CT; RADIATION-THERAPY; LOCAL RECURRENCE; F-18-CHOLINE PET/CT;
D O I
10.1016/j.canrad.2014.07.148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Major improvements in the field of radiotherapy planning such as stereotactic radiation therapy, have recently been performed, aiming to the development of personalized therapeutic strategies in patients with biochemical failure of prostate cancer. However, this needs an early and accurate location of sites of recurrence. Development of multimodality magnetic resonance imaging (MRI) and positron emission tomography (PET) permits to consider this objective. Thus, it is worthwhile to apprehend the respective performance of these imaging techniques in order to rationalize their use. We propose a review of the recent literature organized by technique and by location, regarding the performance of multimodality MRI and PET for restaging of patients with biochemical failure of prostate cancer initially treated with curative intent. (C) 2014 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 50 条
[31]   PET/MRI and prostate cancer [J].
Piert M. ;
El Naqa I. ;
Davenport M.S. ;
Incerti E. ;
Mapelli P. ;
Picchio M. .
Clinical and Translational Imaging, 2016, 4 (6) :473-485
[32]   Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET [J].
Phillip J. Koo ;
Jennifer J. Kwak ;
Sajal Pokharel ;
Peter L. Choyke .
Current Oncology Reports, 2015, 17
[33]   Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body 68 Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy? [J].
Morawitz, Janna ;
Kirchner, Julian ;
Hertelendy, Johannes ;
Loberg, Christina ;
Schimmoeller, Lars ;
Dabir, Mardjan ;
Haeberle, Lena ;
Mamlins, Eduards ;
Antke, Christina ;
Arsov, Christian ;
Antoch, Gerald ;
Sawicki, Lino M. .
EJNMMI RESEARCH, 2022, 12 (01)
[34]   Value of bimodal 18F-choline-PET/MRI and trimodal 18F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy [J].
Paparo, Francesco ;
Piccardo, Arnoldo ;
Bacigalupo, Lorenzo ;
Romagnoli, Andrea ;
Piccazzo, Riccardo ;
Monticone, Michela ;
Cevasco, Luca ;
Campodonico, Fabio ;
Conzi, Giuseppe Maria ;
Carmignani, Giorgio ;
Rollandi, Gian Andrea .
ABDOMINAL IMAGING, 2015, 40 (06) :1772-1787
[35]   A prostate MRI atlas of biochemical failures following cancer treatment [J].
Rusu, Mirabela ;
Kurhanewicz, John ;
Tewari, Ashutosh ;
Madabhushi, Anant .
MEDICAL IMAGING 2014: COMPUTER-AIDED DIAGNOSIS, 2014, 9035
[36]   Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study [J].
Miyake, Makito ;
Tanaka, Nobumichi ;
Asakawa, Isao ;
Morizawa, Yosuke ;
Anai, Satoshi ;
Torimoto, Kazumasa ;
Aoki, Katsuya ;
Yoneda, Tatsuo ;
Hasegawa, Masatoshi ;
Konishi, Noboru ;
Fujimoto, Kiyohide .
RADIATION ONCOLOGY, 2014, 9
[37]   Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study [J].
Makito Miyake ;
Nobumichi Tanaka ;
Isao Asakawa ;
Yosuke Morizawa ;
Satoshi Anai ;
Kazumasa Torimoto ;
Katsuya Aoki ;
Tatsuo Yoneda ;
Masatoshi Hasegawa ;
Noboru Konishi ;
Kiyohide Fujimoto .
Radiation Oncology, 9
[38]   Delineating biochemical failure with 68Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer [J].
Hruby, George ;
Eade, Thomas ;
Kneebone, Andrew ;
Emmett, Louise ;
Guo, Lesley ;
Ho, Bao ;
Hsiao, Ed ;
Schembri, Geoff ;
Hunter, Julia ;
Kwong, Carol .
RADIOTHERAPY AND ONCOLOGY, 2017, 122 (01) :99-102
[39]   Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer [J].
Lake, Spencer T. ;
Greene, Kirsten L. ;
Westphalen, Antonio C. ;
Behr, Spencer C. ;
Zagoria, Ronald ;
Small, Eric J. ;
Carroll, Peter R. ;
Hope, Thomas A. .
EJNMMI RESEARCH, 2017, 7
[40]   Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence [J].
Poncet, D. ;
Arnoux, V. ;
Descotes, J. -L. ;
Rambeaud, J. -J. ;
Verry, C. ;
Terrier, N. ;
Boillot, B. ;
Dubreuil, J. ;
Lanchon, C. ;
Carnicelli, D. ;
Fiard, G. ;
Long, J. -A. .
PROGRES EN UROLOGIE, 2015, 25 (06) :325-330